Targeting multiphosphorylated tau: technical and clinical validation of a new Simoa® assay for CSF and plasma detection of tau simultaneously phosphorylated at T181 and T231

Anna Lidia Wojdała, Giovanni Bellomo, Lorenzo Gaetani, Dandan Shan, Lucilla Parnetti, Davide Chiasserini
doi: https://doi.org/10.1101/2023.06.08.23291128

Article usage

Article usage: June 2023 to July 2025

AbstractFullPdf
Jun 20232461450
Jul 202341726
Aug 2023321710
Sep 202325105
Oct 202337915
Nov 202322410
Dec 20232069
Jan 202416114
Feb 202417410
Mar 202424213
Apr 20241234
May 20241655
Jun 202416314
Jul 202418410
Aug 20246314
Sep 202417410
Oct 20241849
Nov 202420315
Dec 2024447
Jan 202510115
Feb 2025122813
Mar 2025283128
Apr 2025302439
May 2025192220
Jun 2025241111
Jul 2025024
Back to top
Posted June 12, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Targeting multiphosphorylated tau: technical and clinical validation of a new Simoa® assay for CSF and plasma detection of tau simultaneously phosphorylated at T181 and T231
Anna Lidia Wojdała, Giovanni Bellomo, Lorenzo Gaetani, Dandan Shan, Lucilla Parnetti, Davide Chiasserini
medRxiv 2023.06.08.23291128; doi: https://doi.org/10.1101/2023.06.08.23291128
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area